Furthermore, we suggested an underlying regulatory mechanism of Hsp90-Acsl4 as a potential therapeutic pathway to enhance the effect of ferroptosis-inducing therapy for gliomas. This evidence concerns the gene ACSL4 and central nervous system cancer.